One-two punch of palbociclib and paclitaxel shows promise against advanced breast can

[News]

Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the...

More... (http://www.medicalnewstoday.com/releases/303815.php)